Indian drug maker Wockhardt recently acquired US-based speciality drugs company Morton Grove Pharmaceuticals, which has annual sales of $52 million. Though officially its not been confirmed, Wockhardt has reportedly paid nearly $38 million for the Illinois-based company. This ends a long wait for the Mumbai-based drug maker, which had been scouting for acquisition in the US market for over two years, and also brings it closer to its Indian rival Cipla, which had signed a supply agreement with Morton Grove in 2004.

Be a part of Elets Collaborative Initiatives. Join Us for Upcoming Events and explore business opportunities. Like us on Facebook , connect with us on LinkedIn and follow us on Twitter , Instagram.

Related Pharma


whatsapp--v1